Opexa Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Opexa Therapeutics, Inc.
CIK #0001069308
EDGAR Form CIK 2011 - 2025
10-K [0001069308]
10-Q [0001069308]
3 [0001069308]
4 [0001069308]
8-K [0001069308]
D [0001069308]
SC 13D [0001069308]
SC 13G [0001069308]
Form 13D/13G Filer Form 13D/13G Subject Filed
Hirschman Orin ACER Therapeutics Inc [2020-05-19]
Nantahala Capital Management LLC ACER Therapeutics Inc [2019-02-14]
Vivo Opportunity LLC ACER Therapeutics Inc [2018-09-17]
TVM Life Science Ventures VI LP ACER Therapeutics Inc [2018-02-16]
Schelling Chris ACER Therapeutics Inc [2017-09-29]
Avego Healthcare Capital LLC ACER Therapeutics Inc [2017-09-28]
Frigate Ventures LP Opexa Therapeutics Inc [2015-04-16]
Zocchi Nicholas J Opexa Therapeutics Inc [2013-09-27]
Capital Ventures International Opexa Therapeutics Inc [2013-08-16]
Sabby Management LLC Opexa Therapeutics Inc [2013-02-11]
Form 3/4/5 Subject 2011 - 2025
Aselage Steve
Acer Therapeutics Inc.
Davis Jefferson E
Palmin Harry S
Schelling Chris
Joseph Donald
Dunn John Michael
Quartel Adrian W
Griffin Michelle Renee
Hayden Tanya
Klopp John Michael
Paul Bernard H
Amello Jason
Seibt Matthew
Andrews William T.
Jutt-Eghbali Salma
Beeby Reshentha
Birner Hubert
Leatt Gary
Fischer Stefan
TVM Life Science Ventures VII L.P.
Schuhsler Helmut
Marengere Luc
TVM Life Science Ventures VI GmbH & Co KG
TVM Life Science Ventures VI LP
Wanless Mark
Steiner Robert D
Barabe Timothy C
Maderis Gail J
Richman Michael
Seaman Scott B
Rill Donna R
Healey Don
Warma Neil K
Radhakrishnan Karthik
Hartung Hans-Peter
Jorden David Emerson
Thompson Jaye
Terms | Privacy | Guide
tony@aum13f.com